Overexpression of the dominant-negative isoform of IKAROS in CD34+ cells from CML patients resulted in inhibition of IKAROS activity and increased differentiation into basophils (184). The gene discussed is IKZF1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.